Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-019733

Chief Executive Officer sold 90,000 shares at an average $57.40 ($5,166,298)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2026-01-20 Sale 10b5-1 −21,433 $51.61 $1,106,157 202,768 D: show line 1 in the form
Kulkarni Samarth Chief Executive Officer 2026-01-20 Sale 10b5-1 −8,567 $52.10 $446,341 194,201 D: show line 2 in the form
Kulkarni Samarth Chief Executive Officer 2026-01-22 Sale 10b5-1 −60,000 $60.23 $3,613,800 134,201 D: show line 3 in the form
Open-market sales · 90,000 sh · avg $57.40 · $5,166,298
Loading xslF345X05/ownership.xml…